# A Study of GQ1010 in Subjects With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06464055/  
OnCo record `nct06464055` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Dose Escalation in advanced solid tumours, run by GeneQuantum Healthcare (Suzhou) Co., Ltd., now recruiting.

## Summary

A Study of GQ1010 in Subjects With Advanced Solid Tumors. ClinicalTrials.gov record last updated 2025-02-10: recruiting. Enrollment is planned at 260 participants. Primary completion is estimated at 2028-05-23. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications. Registered interventions: Dose Escalation, Dose Expansion1, Dose Expansion2, Dose Expansion3, phase II. Registered primary measures: Phase I/II: Incidence and Severity of Adverse Events (AEs); Phase Ia: Dose Limiting Toxicities (DLTs); Phase Ia: Maximal Tolerance Dose (MTD) or recommended doses for dose expansion (RDEs).

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06464055
- Phase: 1/2
- Setting: A Study of GQ1010 in Subjects With Advanced Solid Tumors
- Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.
- Enrolled: 260

## Notes

- ClinicalTrials.gov record last updated 2025-02-10: recruiting. Enrollment is planned at 260 participants. Primary completion is estimated at 2028-05-23. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT06464055: https://clinicaltrials.gov/study/NCT06464055

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- targets: [TROP2](https://onco.cc/targets/trop2/)
- companies: [GeneQuantum Healthcare (Suzhou)](https://onco.cc/companies/genequantum-healthcare-suzhou/)
- drugs: [BHV-1510](https://onco.cc/drugs/bhv-1510/)

---
JSON: https://onco.cc/api/v1/entities/nct06464055.json